Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: Gleason grade groups 2 and 3 and predict the risk of biochemical recurrence
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
This study demonstrates the ability of a protein-based signature to risk-stratify prostate cancer patients with Gleason grade groups 2 and 3 and predict the risk of biochemical recurrence.
This study demonstrates the ability of a protein-based signature to risk-stratify prostate cancer patients with Gleason grade groups 2 and 3 and predict the risk of biochemical recurrence.
APA
Zhong Q, Sun R, et al. (2026). Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients.. Life science alliance, 9(2). https://doi.org/10.26508/lsa.202503547
MLA
Zhong Q, et al.. "Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients.." Life science alliance, vol. 9, no. 2, 2026.
PMID
41326175
Abstract
This study demonstrates the ability of a protein-based signature to risk-stratify prostate cancer patients with Gleason grade groups 2 and 3 and predict the risk of biochemical recurrence.
같은 제1저자의 인용 많은 논문 (5)
- Associations between respiratory diseases and lung cancer risk: a secondary analysis of the large-scale prospective UK biobank cohort.
- Upregulation of LINC00665 Correlates with Aggressive Hepatocellular Carcinoma and Poor Prognosis.
- Dynamic postoperative prognosis and follow-up optimization for gastric cancer patients after neoadjuvant therapy: a multicenter retrospective study.
- [Long-term oncological safety of robotic total gastrectomy for locally advanced proximal gastric cancer: a 5-year noninferiority comparison based on the FUGES-014 study].
- Comparison of a submucosal and subserosal approach in ICG-guided laparoscopic lymphadenectomy in gastric cancer patients: long-term outcomes of a phase 3 randomized clinical trial.